Capital7 invests in Allied BioScience

Allied BioScience, a maker of residual antiviral surface coating, has secured an undisclosed amount of Series C funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this